Literature DB >> 10706095

Methylation patterns in human androgen receptor gene and clonality analysis.

S J Jang1, L Mao.   

Abstract

Tumor clonality, an important issue in tumor biology, has been analyzed using X-chromosome inactivation studies based on the differential methylation patterns of active and inactive alleles. Recently, a PCR-based androgen receptor gene (AR) analysis method was developed that takes advantage of highly polymorphic CAG repeats and nearby HpaII and HhaI sites in exon 1 of AR at the Xq13 region. However, the data from this assay, which is now widely used, are sometimes uninterpretable and irreproducible for some currently unclear reason. To determine that reason, we analyzed a panel of lung cancer cell lines, using HpaII or HhaI restriction enzymes, methylation-specific PCR, and bisulfite genomic sequencing of the polymorphic CAG repeat site of AR exon 1, including nearby CpG sites. We found direct evidence of a variable methylation pattern at the restriction sites that prevented proper enzyme cleavage in two lung cancer cell lines (NCI-H292 and NCI-H1944) obtained from female patients who had a polymorphic CAG repeat in AR exon 1. Our data suggest that methylation patterns at the CpG sites of AR exon 1 are complicated and vary among different individuals. Therefore, the reliability of the PCR-based clonality analysis may require further evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706095

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Bisulfite genomic sequencing of microdissected cells.

Authors:  A Kerjean; A Vieillefond; N Thiounn; M Sibony; M Jeanpierre; P Jouannet
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

2.  Presence of 5-methylcytosine in CpNpG trinucleotides in the human genome.

Authors:  Juna Lee; Se Jin Jang; Nicole Benoit; Mohammad O Hoque; Joseph A Califano; Barry Trink; David Sidransky; Li Mao; Chulso Moon
Journal:  Genomics       Date:  2010-04-09       Impact factor: 5.736

3.  Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet.

Authors:  Taketo Uchiyama; Norifumi Tatsumi; Sahoko Kamejima; Tsuyoshi Waku; Ichiro Ohkido; Keitaro Yokoyama; Takashi Yokoo; Masataka Okabe
Journal:  Hum Cell       Date:  2016-09-02       Impact factor: 4.174

Review 4.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  Severe X-linked chronic granulomatous disease in two unrelated females.

Authors:  Sylvie Chollet-Martin; Anne Lopez; Catherine Gaud; Dominique Henry; Bertrand Stos; Jamel El Benna; Gaëlle Chedevile; Dominique Gendrel; Marie-Anne Gougerot-Pocidalo; Bernard Grandchamp; Bénédicte Gérard
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

6.  Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles.

Authors:  Zheming Lu; Jindong Sheng; Yujie Zhang; Jianhua Deng; Yong Li; Aiping Lu; Juan Zhang; Huan Yu; Min Zhang; Zikai Xiong; Hai Yan; Bill H Diplas; Youyong Lu; Baoguo Liu
Journal:  J Pathol       Date:  2016-04-01       Impact factor: 7.996

7.  Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity.

Authors:  Xinrong Hu; Tianyun Pang; Anna Asplund; Jan Pontén; Monica Nistér
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

8.  Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders.

Authors:  Marta Codina-Solà; Benjamín Rodríguez-Santiago; Aïda Homs; Javier Santoyo; Maria Rigau; Gemma Aznar-Laín; Miguel Del Campo; Blanca Gener; Elisabeth Gabau; María Pilar Botella; Armand Gutiérrez-Arumí; Guillermo Antiñolo; Luis Alberto Pérez-Jurado; Ivon Cuscó
Journal:  Mol Autism       Date:  2015-04-15       Impact factor: 7.509

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.